FDA panel recommends harmonizing COVID-19 vaccine composition
A Food and Drug Administration advisory committee unanimously voted today to recommend harmonizing the composition of all COVID-19 vaccine primary series and booster doses administered in the U.S. For example, the composition of all vaccines administered going forward might be bivalent.
Related News Articles
Headline
If President Biden signs as expected Congress’ joint resolution ending the COVID-19 national emergency immediately, the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services yesterday released FAQs on COVID-19 coverage after the public health emergency ends. Developed by the…
Headline
Responding yesterday to a Senate Health, Education, Labor and Pensions Committee request for input on reauthorization of the Pandemic and All-Hazards…
Headline
Learn how Advocate Children's Hospital is managing the “immunity gap” created by social distancing to persevere through the triple threat of COVID-19, RSV and…
Headline
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations…
Headline
Health and Human Services Secretary Xavier Becerra this week amended the February 2020 COVID-19 emergency use authorization declaration so that the Food…